Two shock-inducing toxins that result in similar eventual outcome of disease were studied to determine host gene expression responses, for correlation of both similar and unique gene patterns. We initially used differential display (DD)-PCR and identified 859 cDNA fragments that were differentially expressed after 16 h of in vitro exposure of human peripheral blood mononuclear cells (PBMC) to staphylococcal enterotoxin B (SEB). Upon further examination using custom cDNA microarrays and RT-PCR analysis, we found unique set of genes to each toxin (SEB or lipopolysaccharide (LPS)), especially at early time periods. By 16 h, there was a convergence of some gene expression responses and many of those genes code for proteins such as proteinases, transcription factors, vascular tone regulators, and respiratory distress. In an attempt to replicate the findings in vivo, monkeys were challenged with SEB and the resultant gene expression responses indicated a pattern typical of SEB exposure when compared to LPS, with a similar outcome. We provide evidence that vastly diverse global gene analysis techniques used in unison can not only effectively identify pathogen-specific genomic markers and provide a solid foundation to mechanistic insights but also explain some of the toxin-related symptoms through gene functions. Genes and Immunity (2005) 6, 84-94.
Introduction
Staphylococcal enterotoxins (SEs) constitute a family of proteins that are the causative agents for food poisoning, skin disorders, toxic shock and autoimmune disorders. 1, 2 SEs bind to T-cell receptors and major histocompatibility antigen complexes and induce massive activation of T cells in the host. The preliminary symptoms induced by staphylococcal enterotoxin B (SEB) are transient vomiting/nausea, persistent diarrhea, vertigo and muscle weakness, which can appear within a few hours after exposure to the toxin. The symptoms that follow within 24 h after exposure include nausea, diarrhea, hypotension, and vasodilation of blood vessels in kidneys and other organs. 3 Recent studies illustrate extensive perivascular edema in numerous organs. 4 Vascular leakage and pathological hypotension eventually lead to irreversible shock, multiorgan failure and death at about 44-66 h postexposure in nonhuman primates (NHP). 5 The molecular sequence of events induced by these toxins include a massive cytokine release, and strategies that show a limited success at o4 h postexposure. Furthermore, clinical trials targeting cytokines and their receptors show unsatisfactory results in treatment of septic shock. 6 Recent improved outcomes for treatment of septic shock is seen by targeting microemboli (thought to be a major contributor to the vascular leakage). 7, 8 Lipopolysaccharide (LPS), a small unit of endotoxin from the cell wall of Gram-negative organisms, causes the classic induction of septic shock. LPS binds to toll like receptor and CD14 and stimulates many innate immune responses including secretion of cytokines, activation of macrophages and lymphocytes. 9, 10 Superantigen SEB similarly elicits a massive release of cytokines in peripheral blood mononuclear cells (PBMCs).
Although each of these two agents in both humans and animal models, result in akin eventual outcome especially related to vascular collapse, each proceeds with individual initiation steps and somewhat disparate effects during the course of the insult. For instance, SEB induces high level of expression of CD69 while LPS does not (C Mendis, unpublished results). LPS swiftly elevates tumor necrosis factor-alpha (TNF-a) production, whereas SEB induces only modest changes (C Mendis, unpublished results). Although there are well-known individual differences, SEB and LPS each can initiate a storm of cytokines yet have a unique molecular mechanism in the induction of sepsis. [11] [12] [13] Since many pathogenic agents ultimately lead to lethal shock, the present study was designed to investigate global gene expression patterns induced in the host, identify common gene patterns beyond the inflammatory mediator system and gain some understanding in later events that could present common therapeutic targets. In addition, we make an attempt to differentiate the two shock-inducing agents by utilizing each's gene response pattern using differential display-polymerase chain reaction (DD-PCR) and cDNA microarrays. DD-PCR, cDNA microarrays, serial analysis of gene expression (SAGE) and subtractive hybridization are tools that examine the expression of a large number of genes with a minimum amount of RNA.
In our pursuit to comprehend the molecular mechanisms induced by these two toxins, we have examined the host gene expression patterns induced at 2, 4, 6, 8, 12, 24, 48 and 72 h postexposure in human PBMC through reverse transcription (RT)-PCR for a set of DD-PCR identified genes in our lab to weed out noise and achieve consistent results (results not included). PBMCs were chosen since both SEB and LPS predominantly target the lymphoid system and these cells are readily available from both patients and animal models. Once a SEBspecific gene profile was identified, we further extended our study by comparing the expression pattern to LPS. In addition, we correlated in vitro gene expression patterns of some of the genes to the in vivo findings obtained from SEB-challenged NHP.
In this paper, we determine the host gene patterns using DD-PCR, confirm and compare gene expression patterns using custom microarrays, evaluate timedependent gene expression through RT-PCR and quantify gene expression through real-time PCR and Northern hybridization. Furhermore genes induced by SEB and LPS were identified as early as 2 h (hours before fullblown lethality occurs) and a potential mechanism of action for SEB was deduced.
Results

Gene expression changes identified by differential display
The changes in gene expression induced by SEB in PBMC were examined initially using DD-PCR. Remarkably, while a great majority of transcripts did not exhibit significant changes, a few showed appreciable up-and downregulation in the SEB-treated cells. A total of 859 PCR products were isolated, cloned, sequenced and identified. The gene expression profiles of the normal and SEB-treated PBMCs had unique differences as expected. In the SEB-treated cells, we observed a higher number of genes to be significantly upregulated compared to the number of downregulated genes. Table 1 includes 44 genes that were differentially expressed, out of which 32 genes were upregulated and 12 genes were downregulated. Two of the most highly expressed genes included dendritic cell protein and cathepsin-L. Both of these genes are known for their involvement with antigen-specific immunity and major histocompatibility complex (MHC) II class related antigen presentation, which are two common events seen upon SEB infection.
Some of the other highly expressed genes included interleukin (IL) 6, 17, 8, and monocyte chemotactic protein-3 (MCP-3), which are proinflammatory mediators. In addition, novel genes and genes that have never been implicated in either SEB-induced toxicity or in septic shock included hypoxia-inducible factor-1 (HIF-1), guanylate binding protein2 (GBP-2) and connective tissue activating protein III (CTAP-III) ( Table 1) .
Confirmation of the DD-PCR results by custom microarray
To confirm the alterations observed through DD-PCR, we designed custom microarrays containing genes of interest that were identified using DD-PCR. These genes were chosen based on their function such as proinflammatory mediators (IL-8, IL-17, IL-6 and MCP-3), involvement in cell death (Cathepsin and RNA helicase), transcription factors (TF-20) and heme-based proteins (Ferritin). In order to find a set of genes specific for SEB, we compared the results of DD-PCR to cDNA microarray experiments. Both techniques demonstrated similar activation patterns (28 of 32 genes, Figure 1 ), which provided an efficient way of confirming the data with greater confidence. As shown in Figure 1 , IL-8, cathepsin-L, Ferritin Heavy chain and the gene, Highly Expressed in Cancer (HEC), were massively upregulated by SEB exposure while CTAP-III, cytochrome P-450, Proteoglycan versican-1 and Ras Inhibitor genes were significantly downregulated. We also used Atlast glass microarrays to compare the gene expression profiles of SEB and LPS and the data have been shown as clusters of genes induced by SEB and LPS (Figure 2 ). We were able to identify genes that were implicated with common events induced by both toxins as well as genes that showed a distinct expression pattern to either of the toxins.
Confirmation of expression pattern by RT-PCR, real-time PCR and Northern blot analysis A total of 10 selected genes that were identified by DD-PCR were then confirmed by RT-PCR (Table 2) . We further selected two functionally relevant genes, one that was upregulated and one that was downregulated, and utilized three different techniques to confirm their extended expression. HIF-1 gene was upregulated by DD-PCR (Table 1) ; its expression level (Figure 3a ) was then measured using RT-PCR (2.7-fold), Real-time-PCR (11.0-fold) and DD-PCR (nine-fold). As determined by DD-PCR, CTAP-III gene expression was downregulated by SEB (Table 1) . We performed RT-PCR and Northern blot analysis to determine the level of CTAP-III (Figure 3b ). Both techniques showed a similar timedependent downregulation of the gene at 16 h.
Confirmation of expression pattern by ELISA immunoassays
To correlate gene expression with protein expression patterns induced by SEB, we further investigated a set of interleukins using specific ELISA kits. Quantified protein levels using ELISA immunoassays for both IL-2 and IL-6 correlated with previously observed gene expression patterns ( Figure 4) .
Comparison of genes induced by SEB and LPS
To examine our hypothesis that host gene expression patterns would be unique for two similar shock-inducing toxins, we selected a few differentially expressed genes identified by both DD-PCR and microarray analysis (Table 1 and Figure 2 ) and performed RT-PCR to analyse their level of expression at early (2 h) and late (16 h) time periods of exposure. SEB and LPS showed both similarities and differences in their expression patterns of these selected genes (Table 3) . Performed RT-PCR analysis showed that both toxins downregulated CTAP-III expression over time (Table 3) . Even though both cathepsin-L and NDFP-2 genes were upregulated, the levels differed between SEB and LPS (Table 3) . Cathepsin-L expression was upregulated 6.2-fold by SEB and only 2.3-fold by LPS (at 2 h); however, neither SEB nor LPS did change the expression of NDFP-2 at 2 h. Both toxins were able to upregulate the expression of cathepsin-L and NDFP-2 after 16 h of exposure. IL-6 and IL-17 are two other genes that showed a clear timedependent upregulation by both toxins; however, the SEB-induced effect was more dramatic. RT-PCR analysis showed a 52-fold upregulation of IL-6 within 2 h of SEB Each gene that was identified according to the differential display procedure, cloned into a TOPO-TA vector, and sequenced as described in Experimental Procedure. A partial list of the genes that were identified using BLASTN algorithm search engine using NCBI/EMBL databases together with their differential expression values are listed in Table 2 . The genes that did not match any available sequences in the NCBI/ EMBL database are indicated as novel for identification purposes. Each gene was quantified by digitizing the bands (from two different DDPCR experiments done in duplicates) and the fold change was determined after comparing the values to the control samples and represented together with the respective standard deviation values.
exposure and seven-fold with LPS, but IL-17 expression was induced only by SEB at 2 h (Table 3) . A timedependent upregulation of HIF-1 was observed in SEBinduced human PBMCs, while LPS had a negative and no effect on HIF-1 expression at 2 and 16 h respectively (Table 3) . GBP-2 expression was clearly upregulated after 2 h of SEB exposure and stayed elevated even after 16 h of exposure. However, LPS had no effect on the expression of GBP-2 in human PBMCs (Table 3) .
In vivo gene changes induced by SEB in a monkey model The findings of in vitro studies of humans PBMC were verified in PBMCs isolated from aerosol SEB-challenged monkeys. The animals were treated with a sublethal dose of the toxin, which caused incapacitation. Each monkey was used as its own control in a saline sham experiment. Unique gene expression patterns were observed by RT-PCR for a set of selected genes in blood samples as early as 30 min postexposure. Expression of IL-6, IL-2, ferritin, and GBP-2 were upregulated within 30 min of SEB exposure ( Figure 5 ). Both IL-6 and ferritin expression levels were increased approximately five-fold by SEB as compared to saline treatment. GBP-2 and IL-2 expression were upregulated about 80-and 2-3-fold respectively in SEB-exposed samples. Therefore, the gene changes observed within 30 min were not only significant, but also confirmed the results observed in vitro with human PBMCs.
Schematic model of SEB action in human PBMCs
Based on our current genetic and protein data and what is known in the literature, we have identified some of the pathways that are regulated by SEB. The proposed model illustrates ( Figure 6 ) the complexity of the cascade of events that could be involved in the signaling mechanisms and the possible interaction of these multiple pathways induced by SEB in human PBMCs.
Discussion
In an attempt to understand the complex molecular events induced in the host during lethal shock, we performed gene expression analysis to identify and profile genes of the host PBMCs. Such a study is also very attractive due to the unsuccessful treatment of lethal shock probably due to the early activation of numerous cascades of cellular mediators and the inability to successfully target cytokines and inflammatory mediators in clinical trials. 6 The systematic examination of the gene expression profiles in human PBMC by bacteria and bacterial products divulge qualitative and quantitative differences leading to a possible mechanism of action.
14 Global gene analyzing methods such as DD-PCR is used in multiple studies to assess the gene expression pattern of vascular endothelial cells, which accompanies the inflammatory reaction of atherosclerotic lesions 15 and to identify genes that are expressed in airway epithelium induced by glucocorticoid and cytokines. 16 In the current study, DD-PCR was employed to amplify the entire RNA population of human PBMCs treated with SEB, which yielded 859 significantly altered genes. Out of the 859 genes, some did not match with any accessible sequences in the genbank database. 17 These novel genes have been sequenced and together with a set of unique genes may present possibilities for the use as potential new therapeutic targets and the functions of these genes may account for the pattern of impending illness induced by SEB.
DD-PCR proved to be a valuable analyzing tool to identify genes that may have otherwise gone undetected though other high-throughput methods as commercial micro-arrays. Genes such as GBP-2 and CTAP-III identified by DD-PCR, which explains some of the functions of SEB yet has never been associated with SEB were not apparent using commercial arrays or blots. We speculate that there may be forms of some of these genes that can be differentiated using DDPCR but are analyzed as a single unit when using predesigned primers. One case in point is GBP-2, which was a striking finding of DDPCR. We further investigated the specificity of the genes to SEB by comparing the gene expression patterns of SEB to LPS through cDNA microarrays. CDNA microarray is a state-of-the-art technique that not only requires minute amounts of total RNA but also is an excellent method to validate multiple genes in one experiment. 18 Cluster analysis performed on genes altered by SEB and LPS indicated both a similar and distinct expression pattern. Yet, published literature has shown that distinct gene expression patterns can be obtained for individual and temporal variations. Here (Figure 2 ) we tried to report the genes that are consistently expressed in Response of lymphoid cells to SEB C Mendis et al multiple donors irrespective of the gender, age, etc. The individual profiling patterns described in similar literature was treated as noise (specific for a subset of experiments) and was excluded from the results as one of our goals of this study was to come up with a consistently altered set of genes for both SEB and LPS Figure 2 Cluster analysis of SEB-and LPS-induced genes. Gene expression patterns of human PBMCs treated with SEB or LPS at 100 ng/ml for 16 h organized by unsupervised hierarchical clustering. Cluster analysis performed on genes altered by SEB and LPS indicated both similar and distinct expression patterns and were from multiple (six) donors analyzed as replicates of two on multiple days. The global gene expression patterns of PBMCs were sorted based on similarity by hierarchical clustering. Genes that showed significant variations in expression using ANOVA with a Po0.005 were selected from the total data set. The variations in gene expression are shown in matrix format. The scale extends from 0.125-to 8-fold compared to the control untreated cells.
Response of lymphoid cells to SEB C Mendis et al
(irrespective of individual variations), which in turn can be safely used as a set of markers for a larger population irrespective of their demographics. The analysis of the expression profile using cDNA microarrays revealed the upregulation of many genes, upon 16 h exposure of PBMC to both toxins. These genes encoded for proteins involved in cell migration and homing, including the chemokines and cytokines such as IL-8, CTAP-III, IL-6, IL-17, IL-1, MCP-3, and the interferon gamma-induced protein. Induction of high levels of IL-6 by SEB is well documented in the literature. Experiments in primates show significant increases in levels of IL-2 and IL-6 after 4 h of exposure to nonlethal doses of SEB. 19 In addition to the chemokine response, proinflammatory cytokines (IL-2, IL-12 receptor-b2 and TNF-a-induced protein and its receptors), heat shock protein (HSJ2) and signaling enzymes (phospholipase A2 and phospholipase C) were also upregulated by both SEB and LPS. The genes mentioned above are also induced during stress or inflammation processes, common events implicated upon exposure with either of these toxins.
IL-2 is a potent cytokine involved in cellular activation and proliferation and is activated in T cells through numerous signal transduction pathways including JAK/ STAT and MAPK. 20 IL-2 was initially excluded from both Figure 2 and Table 1 due to the relatively low expression level (two-fold through microarrays and DD-PCR) as well as widely known implications with SEB. Yet, IL-2 was made part of the final set of genes due to its ability to maneuver as a functionally relevant (inflammatory response) marker gene. IL-6, which is associated with inflammation and hematopoesis, as well as neuronal differentiation and bone loss 21 showed the utmost protein expression of the studied interleukins, while both IL-2 and IL-6, which are responsible for inflammation, showed similar expression patterns at both gene and protein levels, thus further validating our findings. Furthermore, the observed expression levels of a few selected genes activated by SEB in vitro showed a similar alteration when analyzed in SEB-challenged monkeys ( Figure 5 ).
Other genes upregulated by both toxins included matrix metalloproteinase, MMP-9, integrins, vascular endothelial growth factor (VEGF) and proteases such as calpain, cadherins and cathepsins. Categorized as a lysosomal proteinase, cathepsin-L plays a vital role in presenting antigenic peptides to the immune system on MHC class II molecules. 22 There were genes that were distinct in their expression profile due to the upregulation by only one toxin and not by the other. IL-3 alpha-receptor was vastly upregulated by LPS, but SEB did not have any effect. GBP-2 and HIF-1 were upregulated only by SEB and not by LPS. Further analysis of GBP-2 gene indicated specificity to SEB when compared to eight other biological threat agents (data not shown).
A few genes (CTAP III, HIF-1 and GBP-2) that may be crucial in predicting the course of the imminent illness A set of genes identified by DD-PCR was further examined by RT-PCR to compare the level of gene expression. After designing specific primers for each gene of expression, RT-PCR reactions were performed on samples treated with SEB (100 ng/ml) at 16 h as described in Materials and methods. Identical total RNA samples were used for both RT-PCR and DD-PCR, the bands of PCR products were digitized using a Bio RAD Molecular Imager R Fx (Bio-RAD Hercules, CA, USA) after normalizing with a housekeeping gene (18S rRNA), and quantitated using NIH image. All reactions were repeated twice and the results are reported as mean values together with the standard deviations. Response of lymphoid cells to SEB C Mendis et al were identified as early as 2 h, way before the symptoms appear. CTAPIII, a protein released from activated platelets, was downregulated as early as 2 h by both SEB and LPS. The downregulation of this gene was confirmed with microarray, RT-PCR and Northern hybridization. Observed near sites of inflammation and vascular lesions, 23 CTAP-III plays a role in the early stages of tissue repair and inflammation. Since both toxins downregulate CTAP-III, its decrease perhaps may explain the increased vascular permeability resulting from the inability to combat vascular lesions that contributes to the development of lethal shock.
Our study also revealed an escalation in the expression of transcription factor HIF-1 by SEB within 2 h of exposure. A key step to hypoxia-inducible transcription activation is the formation of a heterodimeric complex of two helix-loop-helix PAS proteins, 24 which is associated with respiratory distress. The increase in expression of HIF-1 that is involved in respiratory distress could be associated with SEB intoxication. 25 Another cDNA codes for an interferon (IFN)-induced 67 kDa GBP-2, which has an assortment of basic cellular functions such as protein synthesis, signal transduction, intracellular protein transcription and cyclase activity. 26 Even though both toxins are known to cause lethal shock, only SEB showed a substantial upregulation of GBP-2. Although IFN induction is a well-documented effect of SEB, GBP-2 upregulation, which appears highly specific to this toxin, has never been linked to SEB exposure. We observed an upregulation of GBP-2 expression in monkeys as early as 30 min post-SEB exposure when compared to the salinechallenged monkeys, thus reflecting the SEB gene expression pattern previously shown in vitro.
In an attempt to further narrow down the most relevant genes to SEB (specially the genes with a functional significance to SEB and genes that were unique to SEB), we adapted cDNA microarray technique to confirm the expression of 28 genes. Microarray techniques can be efficiently used not only as a high throughput initial screening technique but also as an Figure 4 Protein expression of ILs in SEB-induced human PBMCs. Protein expression was determined from human PBMCs with or without 16-h SEB treatment by ELISA immunoassay and compared to the gene expression as depicted in detail in experimental procedures. The protein data were the average of three separate experiments (unfilled bars) while the gene expression results were from two experiments analyzed as duplicates on high resolution gels (dark, filled bars). Standard errors for all samples were calculated and presented together with fold changes. To compare the enormity of the genes induced by each shock-inducing toxin, total RNA was extracted from SEB-or LPS (100 ng/ml each)-induced human PBMCs, and identical quantities of RNA samples were subjected to RT-PCR. The genes of interest were selected from DD-PCR and primers designed for specific genes. The bands of PCR products were digitized using a BIORAD scanner after normalizing with a housekeeping gene (18S). All data points were obtained from two different experiments (in duplicates) and reported as mean values together with the standard deviations. Gene alteration at 2 and 16 h of both SEB and LPS are illustrated. Response of lymphoid cells to SEB C Mendis et al alternative high throughput confirmational technique. We observed a consistent expression pattern for 87% of the selected genes through both DD-PCR and cDNA microarray techniques, which included genes that are already known to be universally associated with inflammation (IL-2, IL-6 and IL-17) and genes that have never being implicated with SEB but could explain some of the symptoms associated with SEB toxicity or shock such as RNA helicase, ferretin, CTAP-III, GBP-2, and HIF-1. We further investigated the extended expression patterns of a couple of up-and downregulated genes through multiple alternative confirmation techniques. We truly believe that employing multiple confirmational methods to establish a gene expression pattern will have a greater impact on the true representation of the gene expression profile. We investigated the time dependent gene expression profiles of a few crucial genes using RT-PCR (Table 3 and Figure 3 ), quantitated the gene expression levels by Northern analysis and real-time quantitative PCR, showed the correlation of gene and protein expression through ELISA immunoassays, and finally showed a similar expression pattern in an SEBinduced in vivo monkey model.
These reported results lead us to propose a schematic model for SEB action in human PBMCs (Figure 6 ). The ability of SEB/MHC-II and Vb of TCR complex to activate T cells is well documented. 27 Higher than normal (as high as 30%) T-cell activation then results in the induction of a plethora of cytokines such as IL-17, IL-6, TNF-a and IFN-g within a few hours of exposure. The cytokines shown in Figure 6 collectively or discretely are then responsible for turning on cascades of signal transduction pathways and multicellular events. Even though some of the SEB induced pathways and events have been investigated before in various cell types, none has fully addressed the complexity of such events. Here we try to show the intricate nature of superantigen (SEB) action by investigating the gene expression pattern in vitro and then in vivo. Owing to the lack of evidence pointing to any single mechanism to explain the final outcome of SEB in human PBMCs, we believe SEB uses multiple signal transduction pathways, which in turn Response of lymphoid cells to SEB C Mendis et al would induce multiple transcription factors and cellular events. Furthermore, it is also possible for this scenario to be unique to a cell type and to the nature of a toxin (in our case SEB) since LPS induced a unique set of genes in human PBMCs. A clear outcome of this study is the ability of SEB to induce both multiple cellular events and genes. These unique gene expressions consequently would explain some of the symptoms associated with SEB pathogenesis (vascular permeability). Colossal induction of both cytokines (ILs, TNF-a, IFN-g ) and multiple signal kinases (protein kinase, 5-LO and MAPK) are implicated with SEB exposure. 2 The proposed model includes Fas pathway, which has never been directly associated with SEB. It is not surprising to see the activation of FAS-associated components when massive cell proliferation 28 followed by cell apoptosis are two common cellular events linked to SEB induction. We observed the activation of multiple cytokines that is known to activate JAK/STAT pathway and subsequently a variety of different transcription factors (c-Fos and cJun). Moreover, we have also seen the ability of SEB to activate a number of signal pathways in a similar lymphoid cell type (C Mendis et al, unpublished results). Yet, collectively, the above events give a better discernment of the mechanistic aspects of SEB.
One of our major goals was to correlate part of our in vitro data to an in vivo model. When specific genes were chosen for this comparison we chose three highly differentially expressed genes (IL-6, IL-2 and GBP-2, ferritin H (highly upregulated through microarrays)) that were functionally relevant. As it is common to observe drastically different regulation patterns as well regulation strengths between in vivo and in vitro models our strategy was to choose highly differentially expressed genes so that we may have a high probability to see a similar expression pattern. We also tried to choose a gene from one of each of the three categories; genes that were known to be induced by SEB (IL-2 and IL-6), genes that were never implicated with SEB before but explained some of the known functions of SEB (GBP-2) and genes that are functionally relevant to the symptoms associated with SEB (ferritin).
Our ability to find a unique set of genes to differentiate SEB exposure from that of LPS (as early as 30 min postexposure) before the initial illness of these toxins appear (3-4 h) may reveal a molecular pathogenesis blueprint that will enable us to design novel methods for stage-specific intervention. The approach utilized in the present study was part of an aim to create a library of gene responses to various toxic agents. In this paper we have shown the identification of a set of genes by utilizing multiple gene analyzing techniques as well as a foundation to understand the complex molecular events induced in the host. We believe that such unique marker genes would be pivotal in designing efficient diagnostic assays for early detection upon exposure to such toxic agents in the future.
Materials and methods
Exposure of human PBMCs to SEB in vitro Human lymphocytes and monocytes were prepared from leukopacks obtained from normal human donors using a lymphocyte separation medium (Histopaque 1077, Sigma-Aldrich, St Louis, MS, USA). Lymphocytes and monocytes were further purified and separated by counterflow centrifugation-elutriation, with PBS as the eluant. These cells were mixed in a 4:1 ratio, resuspended at a density of 2.5 Â 10 6 cells/ml in RPMI-1640 medium supplemented with 10% human AB serum, and treated with SEB or LPS (100 ng/ml) for 2-16 h at 371C. Cells were harvested and total RNA isolated using Trizol reagent (Life Technologies, Grand Island, NY, USA).
Exposure of monkeys to aerosol challenge with SEB Monkeys were exposed to saline or SEB (15 mg/kg) by aerosol, and whole blood was collected 30 min after exposure. After the PBMCs were fractionated using a Ficoll gradient, total RNA was isolated using Trizol reagent.
DD-PCR
Reverse transcription was performed using the Hieroglyph mRNA profile kit (Beckman-Coulter, Foster City, CA, USA) and Superscript preamplification system for the first strand cDNA synthesis (Life Technologies, Grand Island, NY, USA). Two-base anchored Oligo-dT primer (AP, total 12 primers) was used for the RT reaction and the resulting cDNAs were then subjected to PCR using one of the 20 arbitrary primers (ARPs) with [a-33 P] ATP for labeling. The 33 P-labeled PCR products were analyzed in duplicates on high-resolution gels (Beckman-Coulter, CA, USA) and autoradiographs were examined for differences (induction/inhibition) in the SEB treated versus untreated samples. Both positive and negative controls were included to avoid false positives. The identified bands were excised, eluted and subcloned into a TOPO-TA vector (New England Biolabs, Beverly, MA, USA). After confirming the validity of the inserts through PCR or restriction assays the amplicons were sequenced using a thermo sequenase kit (USB Corporation, Cleveland, OH, USA). The nucleotide sequences obtained were compared with available sequences from EMBL and GenBank databases.
RT-PCR and Northern analysis
RT-PCR reactions were performed using Superscript amplification kit (Life Technologies, Gaithersburg, MD, USA). Housekeeping gene primers (18S, 15S) were obtained from Clontech Corp. (Palo Alto, CA, USA) and all primers were designed using various primerdesign software. cDNAs of genes of interest were amplified using AmpliTaq polymerase (Applied Biosystems, Branchburg, NJ, USA). For Northern hybridizations, equal quantities of RNA samples isolated from control and toxin treated cells were analyzed on formaldehyde/agarose gels. Nitrocellulose filters containing the transferred RNA were probed with the 33 P labeled cDNA probes and autoradiographs were scanned and digitized using the BioRad Molecular Imager FX (BioRad, Hercules, CA, USA).
Custom cDNA and Atlast glass microarray analysis
Custom microarray experiments were performed to confirm gene alterations observed in DDPCR experiments. Genes of interest were amplified using AmpliTaq polymerase (Applied Biosystems, Branchburg, NJ, USA), sub-cloned using TOPO-TA cloning kits (Invitrogen, Carlsbad, CA, USA) and purified through a high throughput Montage Plasmid purification kits (Millipore Bedford, MA, USA). PCR products containing the inserts (GOI) were resuspended in 3 Â SSC at a concentration of 100-150 ng/ml and deposited at 200 mM center-to-center spacing at 60% humidity on optically flat 25 Â 76 mm glass slides coated with covalently attached linear primary amines (TeleChem International Inc., Sunnyvale, CA, USA) using a SDDC-2 microarrayer (Engineering Sciences, Inc., Toronto, Canada) equipped with a surface contact print head SPH 48 (TeleChem Sunnyvale, CA, USA) and 90-100 mM diameter quill SMP3 Stealth Micro Spotting Pins from TeleChem International Inc. Atlas glass microarrays containing 1176 genes from research genetics were used according to the manufacturer's instructions. Total RNA from Control and SEB-or LPStreated human PBMCs were reverse transcribed and the cDNAs were labeled with Cy3 (Control) or Cy5 (Treated) using the NEN Micromax TSA labeling and detection kit (Perkin Elmer, Boston, MA, USA). The resulting cDNAs were hybridized at 651C to custom microarrays or Atlast glass microarrays, scanned using the Gene Pix 4000B Microarray Scanner (Axon Instruments Inc., Foster City, CA, USA) and the data analyzed using the Gene Pix 3.0 software package.
Clustering analysis
Average linkage hierarchical clustering of an uncentered Pearson correlation similarity matrix was carried out using the program Cluster, and the results were visualized with the program TreeView. 29 The data were analyzed using the GeneSpring TM version 4.1 (Silicon Genetics, San Carlos, CA, USA) to identify patterns of gene regulation in peripheral blood mononuclear cells exposed to SEB and LPS from multiple (six) donors, analyzed in duplicates on multiple days. To normalize for staining intensity variations among arrays, the average difference values for all genes on a given array were divided by the sum of all measurements on that array. In addition, the average difference value for each individual gene was then normalized to itself by dividing all measurements for that gene by the mean of the gene's expression values over all the samples. Normalized values below the background levels in both the control and treated were excluded. To identify genes that showed significant variations in expression between SEB compared to control cells and LPS compared to control cells, an ANOVA test was performed by using Po0.005 as a threshold.
Real-time PCR
Real-time PCR was performed in triplicates using a uniprimer containing a 3 0 oligonucleotide tail (Z sequence) specific for HIF-1 and a housekeeping gene (S15) in an I Cycler (BioRad, Hercules, CA, USA). Total RNA extracted from SEB-induced or control PBMCs were subjected to real-time PCR using Amplifluor universal amplification kit (Intergen, Purchase, NY, USA). Threshold cycle (cT) of each reaction was calculated, and normalized using the cT values of S15 (housekeeping gene).
ELISA immunoassays: Specific kits for each protein of interest were obtained from R&D systems and performed on human PBMCs with or without treatment of SEB according to the manufacturer's instructions (Quantikine R&D systems, Minneapolis, MN, USA). The amount of protein was quantified using the Ceres UV 900-Hdi-plate reader (Bio-Tek Instruments Inc., Winooski, VT, USA).
